Abstract:OBJECTIVE COVID-19 had massive effects on the healthcare system and multifactorial implications for the management of intensive care unit and cerebrovascular patients. This study aimed to assess the effect of COVID-19 on the outcomes of patients with aneurysmal subarachnoid hemorrhage (SAH). METHODS The National Inpatient Sample (NIS) was used to identify patients with nontraumatic SAH (ICD-10 code I60.x). Patients with nonaneurysmal cerebrovascular malformations or traumatic intracranial injuries were excluded. Only patients managed from April to December 2020 were included in the study given the availability of an ICD-10 code for COVID-19. Data on sociodemographic factors, hospital characteristics, comorbidities, NIS SAH Severity Score (NIS-SSS), surgical treatment, and death were acquired. Multivariable analysis was used to assess predictors of both surgical intervention and in-hospital mortality. RESULTS In total, 6984 patients met the study criteria, 359 (5.1%) of whom had COVID-19. Those with COVID-19 were more likely to be younger and male and had a higher All Patient Refined Diagnosis-Related Groups illness severity subclass, and NIS-SSS. Moreover, patients with COVID-19 were less likely to undergo surgery (10.0% vs 23.6%, OR 0.35, p < 0.0001) and had significantly higher mortality rates (48.2% vs 22.7%, p < 0.0001). When controlling for other variables, COVID-19 was an independent predictor of death (OR 1.67, p = 0.0002). Aneurysm surgery was performed in 1597 patients (317 open and 1280 endovascular procedures). There was no difference between the cohorts positive and negative for COVID-19 in terms of time to surgery or type of surgery. CONCLUSIONS COVID-19 had significant impacts on patients with nontraumatic SAH. Specifically, patients with COVID-19 were significantly less likely to undergo surgery and had higher in-hospital mortality rates; however, for patients who did undergo procedural intervention, there was no significant difference in the type of intervention. Multiple factors, from medical acuity to healthcare system limitations, may contribute to these findings. Further retrospective research is needed to identify both specific causes of lower intervention rates and other potential nonaneurysmal causes of SAH in patients with COVID-19.

Brain Arteriovenous Malformation Hemorrhage and Pituitary Adenoma in a COVID-19-Positive Patient

Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature

Vertebral artery dissecting aneurysm rupture under severe COVID-19

Nonaneurysmal subarachnoid hemorrhage associated with COVID-19 infection: A case report

SARS-Cov-2 Infection: A New Risk Factor for Pituitary Apoplexy?

Pituitary apoplexy and COVID-19 vaccination: a case report and literature review

A Case of Spinal Cavernous Hemangioma with Rapidly Worsening Neurological Symptoms after COVID-19 Infection

Concurrent Cerebral, Splenic, and Renal Infarction in a Patient With COVID-19 Infection

Spontaneous Thrombosis in Main Draining Veins of Unruptured Cerebral Arteriovenous Malformations

COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report

Rare Case of a Disappearing Pituitary Adenoma During the Coronavirus Disease 2019 (COVID-19) Pandemic

Bilateral anterior cerebral infarction associated with anatomical variation in a patient with COVID-19: a case report.

COVID-19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients

Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report

COVID-19 Impact on Intraparenchymal Hemorrhage and Surgical Outcomes: A Comprehensive Analysis

Abstract TMP20: Cerebrovascular Injury Associated With COVID-19 And Non-COVID-19 Acute Respiratory Distress Syndrome

Case Report: Superior mesenteric artery vasculitis causing aneurysm following COVID-19 infection

Superior Mesenteric Artery Thrombosis in COVID-19-Positive Patients: A Rare Coincidence

Aneurysmal Subarachnoid Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series

Rates of operative intervention and in-hospital mortality following subarachnoid hemorrhage in patients with COVID-19

[A rare case of multifocal leukoencephalopathy and cerebral stroke after SARS-CoV-2 infection]